1. Tsuneizumi, M, Emi, M, Nagai, H, Kazui, T, Nakamura, Y. . Overrepresentation of the EBAG9 gene at 8q23 associated with early-stage breast cancers. In Clinical cancer research : an official journal of the American Association for Cancer Research, 7, 3526-32. doi:. https://pubmed.ncbi.nlm.nih.gov/11705872/
2. Wirges, Anthea, Bunse, Mario, Joedicke, Jara J, Höpken, Uta E, Rehm, Armin. 2022. EBAG9 silencing exerts an immune checkpoint function without aggravating adverse effects. In Molecular therapy : the journal of the American Society of Gene Therapy, 30, 3358-3378. doi:10.1016/j.ymthe.2022.07.009. https://pubmed.ncbi.nlm.nih.gov/35821635/
3. Azuma, Kotaro, Ikeda, Kazuhiro, Shiba, Sachiko, Tanaka, Shinya, Inoue, Satoshi. 2024. EBAG9-deficient mice display decreased bone mineral density with suppressed autophagy. In iScience, 27, 108871. doi:10.1016/j.isci.2024.108871. https://pubmed.ncbi.nlm.nih.gov/38313054/
4. Ijichi, Nobuhiro, Shigekawa, Takashi, Ikeda, Kazuhiro, Saeki, Toshiaki, Inoue, Satoshi. 2013. Association of positive EBAG9 immunoreactivity with unfavorable prognosis in breast cancer patients treated with tamoxifen. In Clinical breast cancer, 13, 465-70. doi:10.1016/j.clbc.2013.08.015. https://pubmed.ncbi.nlm.nih.gov/24119785/
5. Suzuki, T, Inoue, S, Kawabata, W, Muramatsu, M, Sasano, H. . EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions. In British journal of cancer, 85, 1731-7. doi:. https://pubmed.ncbi.nlm.nih.gov/11742495/
6. Aoki, T, Inoue, S, Imamura, H, Ouchi, Y, Makuuchi, M. . EBAG9/RCAS1 expression in hepatocellular carcinoma: correlation with tumour dedifferentiation and proliferation. In European journal of cancer (Oxford, England : 1990), 39, 1552-61. doi:. https://pubmed.ncbi.nlm.nih.gov/12855262/
智鼠故事 
